These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 30605104)
61. Studying the Effects of Deep Brain Stimulation and Medication on the Dynamics of STN-LFP Signals for Human Behavior Analysis. Golshan HM; Hebb AO; Nedrud J; Mahoor MH Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():4720-4723. PubMed ID: 30441403 [TBL] [Abstract][Full Text] [Related]
62. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies. Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490 [TBL] [Abstract][Full Text] [Related]
63. Pedunculopontine nucleus evoked potentials from subthalamic nucleus stimulation in Parkinson's disease. Neagu B; Tsang E; Mazzella F; Hamani C; Moro E; Hodaie M; Lozano AM; Chen R Exp Neurol; 2013 Dec; 250():221-7. PubMed ID: 24095981 [TBL] [Abstract][Full Text] [Related]
64. The Impact of Deep Brain Stimulation on Sleep in Parkinson's Disease: An update. Zuzuárregui JRP; Ostrem JL J Parkinsons Dis; 2020; 10(2):393-404. PubMed ID: 32250316 [TBL] [Abstract][Full Text] [Related]
65. Advanced target identification in STN-DBS with beta power of combined local field potentials and spiking activity. Verhagen R; Zwartjes DG; Heida T; Wiegers EC; Contarino MF; de Bie RM; van den Munckhof P; Schuurman PR; Veltink PH; Bour LJ J Neurosci Methods; 2015 Sep; 253():116-25. PubMed ID: 26079495 [TBL] [Abstract][Full Text] [Related]
66. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia. Hertel F; Züchner M; Weimar I; Gemmar P; Noll B; Bettag M; Decker C Neurosurgery; 2006 Nov; 59(5):E1138; discussion E1138. PubMed ID: 17143204 [TBL] [Abstract][Full Text] [Related]
68. Improving outcomes of subthalamic nucleus deep brain stimulation in Parkinson's disease. Bari AA; Fasano A; Munhoz RP; Lozano AM Expert Rev Neurother; 2015 Oct; 15(10):1151-60. PubMed ID: 26377740 [TBL] [Abstract][Full Text] [Related]
69. Assessment of the Effect of Subthalamic Deep Brain Stimulation on Sleep Quality of Parkinson's Disease Patients. Oner OG; Sunter G; Jafarova S; Agan K; Seker A; Gunal DI Turk Neurosurg; 2022; 32(3):398-405. PubMed ID: 34936074 [TBL] [Abstract][Full Text] [Related]
70. Theta-alpha oscillations characterize emotional subregion in the human ventral subthalamic nucleus. Rappel P; Grosberg S; Arkadir D; Linetsky E; Abu Snineh M; Bick AS; Tamir I; Valsky D; Marmor O; Abo Foul Y; Peled O; Gilad M; Daudi C; Ben-Naim S; Bergman H; Israel Z; Eitan R Mov Disord; 2020 Feb; 35(2):337-343. PubMed ID: 31758821 [TBL] [Abstract][Full Text] [Related]
71. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation. Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592 [TBL] [Abstract][Full Text] [Related]
72. Intraoperative MRI for optimizing electrode placement for deep brain stimulation of the subthalamic nucleus in Parkinson disease. Cui Z; Pan L; Song H; Xu X; Xu B; Yu X; Ling Z J Neurosurg; 2016 Jan; 124(1):62-9. PubMed ID: 26274983 [TBL] [Abstract][Full Text] [Related]
73. Deep brain stimulation of pedunculopontine tegmental nucleus: role in sleep modulation in advanced Parkinson disease patients: one-year follow-up. Peppe A; Pierantozzi M; Baiamonte V; Moschella V; Caltagirone C; Stanzione P; Stefani A Sleep; 2012 Dec; 35(12):1637-42. PubMed ID: 23204606 [TBL] [Abstract][Full Text] [Related]
74. Delimiting subterritories of the human subthalamic nucleus by means of microelectrode recordings and a Hidden Markov Model. Zaidel A; Spivak A; Shpigelman L; Bergman H; Israel Z Mov Disord; 2009 Sep; 24(12):1785-93. PubMed ID: 19533755 [TBL] [Abstract][Full Text] [Related]
75. Deep brain stimulation of the subthalamic nucleus and the temporal discounting of primary and secondary rewards. Aiello M; Terenzi D; Furlanis G; Catalan M; Manganotti P; Eleopra R; Belgrado E; Rumiati RI J Neurol; 2019 May; 266(5):1113-1119. PubMed ID: 30762102 [TBL] [Abstract][Full Text] [Related]
76. Comparison of oscillatory activity in subthalamic nucleus in Parkinson's disease and dystonia. Geng X; Zhang J; Jiang Y; Ashkan K; Foltynie T; Limousin P; Zrinzo L; Green A; Aziz T; Brown P; Wang S Neurobiol Dis; 2017 Feb; 98():100-107. PubMed ID: 27940307 [TBL] [Abstract][Full Text] [Related]
77. Cortical Activation Elicited by Subthalamic Deep Brain Stimulation Predicts Postoperative Motor Side Effects. Romeo A; Dubuc DM; Gonzalez CL; Patel ND; Cutter G; Delk H; Guthrie BL; Walker HC Neuromodulation; 2019 Jun; 22(4):456-464. PubMed ID: 30844131 [TBL] [Abstract][Full Text] [Related]
78. Deep brain stimulation for Parkinson's disease: defining the optimal location within the subthalamic nucleus. Bot M; Schuurman PR; Odekerken VJJ; Verhagen R; Contarino FM; De Bie RMA; van den Munckhof P J Neurol Neurosurg Psychiatry; 2018 May; 89(5):493-498. PubMed ID: 29353236 [TBL] [Abstract][Full Text] [Related]